📰 Use Listing News
Page 4 - Use Listing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Use Listing. Real-time updates on events, politics, business and more.
October 12, 2022
Last week WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization met to discuss COVID-19 boosters, monkeypox, Ebola, polio and measles, among other concerns. Here’s what they decided.
August 15, 2022
Bharat Biotech has completed the clinical development for phase III trials and booster doses for BBV154 intranasal Covid-19 vaccine.
June 19, 2022
Chairman and MD of Bharat Biotech Dr Krishna Ella said that the data analysis is going on for the world's first nasal Covid vaccine.
June 14, 2022
Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the first protein-based COVID-19 vaccine available in the U.S. GAITHERSBURG, Md., June 8, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious ...
June 8, 2022
GAITHERSBURG, Md., June 7, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing
June 7, 2022
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
June 7, 2022
Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee If Emergency Use Authorization is granted by the...
June 7, 2022
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
June 7, 2022
Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee...
May 20, 2022
GENEVA, May 19 (Xinhua) -- The World Health Organization (WHO) validated on Thursday the CONVIDECIA COVID-19 vaccine developed by Chinese developer CanSino Biologics for emergency use, making it the third Chinese vaccine after Sinopharm and Sinopec having been certified by WHO Emergency Use Listing (EUL).